MA S3012 | 2023-2024 | 193rd General Court
Note: Legislation replaced by S2520
Status
Completed Legislative Action
Sponsorship: Broadly Bipartisan Bill
Status: Passed on January 9 2025 - 100% progression
Action: 2025-01-09 - Signed by the Governor, Chapter 342 of the Acts of 2024
Text: Latest bill text (Introduced) [PDF]
Sponsorship: Broadly Bipartisan Bill
Status: Passed on January 9 2025 - 100% progression
Action: 2025-01-09 - Signed by the Governor, Chapter 342 of the Acts of 2024
Text: Latest bill text (Introduced) [PDF]
Summary
Relativerelative to pharmaceutical access, costs and transparency” (Senate, No. 3012).
Title
Relative to pharmaceutical access, costs and transparency
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2025-01-09 | Signed by the Governor, Chapter 342 of the Acts of 2024 | |
| 2024-12-30 | Senate | Enacted and laid before the Governor |
| 2024-12-30 | House | Motion to reconsider negatived |
| 2024-12-30 | House | Enacted |
| 2024-12-30 | House | Motion to reconsider negatived |
| 2024-12-30 | House | Committee of conference report accepted, in concurrence |
| 2024-12-30 | House | Rules suspended |
| 2024-12-30 | House | Committee reported that the matter be placed in the Orders of the Day for the next sitting, the question being on acceptance |
| 2024-12-30 | House | Referred to the committee on House Steering, Policy and Scheduling |
| 2024-12-30 | Senate | Committee of conference report accepted |
| 2024-12-30 | Senate | Rules suspended |
| 2024-12-30 | Senate | Reported on S2520 |
| 2024-12-27 | Senate | Reported from a committee of conference |
Same As/Similar To
S2520 (Replaced by) 2024-12-30 - Reported by S3012
Massachusetts State Sources
| Type | Source |
|---|---|
| Summary | https://malegislature.gov/Bills/193/S3012 |
| Text | https://malegislature.gov/Bills/193/S3012.pdf |
